| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 6,677 | 9,055 | ||
| Accounts receivable | 32 | 32 | ||
| Prepaid expenses and other current assets | 882 | 592 | ||
| Total current assets | 7,591 | 9,679 | ||
| Fixed assets, net | 300 | 359 | ||
| Restricted cash | 143 | 143 | ||
| Operating lease right-of-use assets | 641 | 755 | ||
| Escrow receivable | 1,008 | 1,004 | ||
| Prepaid expenses and other assets, net | 3 | 38 | ||
| Total assets | 9,686 | 11,978 | ||
| Accounts payable | 580 | 673 | ||
| Accrued expenses | 771 | 727 | ||
| Insurance premium financing liability | 352 | 0 | ||
| Liability to be settled in equity | 218 | 218 | ||
| Operating lease liability, current portion | 528 | 524 | ||
| Total current liabilities | 2,449 | 2,142 | ||
| Operating lease liability, net of current portion | 172 | 298 | ||
| Total liabilities | 2,621 | 2,440 | ||
| Common stock, 0.001 par value 200,000,000 shares authorized, 2,607,962 and 1,898,068 shares issued and outstanding at september 30, 2025 and march 31, 2025, respectively | 3 | 3 | ||
| Additional paid-in capital | 354,607 | 354,535 | ||
| Accumulated deficit | -347,545 | -345,000 | ||
| Treasury stock, 3 shares at cost | 0 | 0 | ||
| Total stockholders equity | 7,065 | 9,538 | ||
| Total liabilities and stockholders equity | 9,686 | 11,978 | ||
VivoSim Labs, INC. (VIVS)
VivoSim Labs, INC. (VIVS)